- In June 2024, Fortis Memorial Research Institute introduced the Gamma Knife Esprit, marking its debut in South Asia. This state-of-the-art Leksell Gamma Knife system ushers in a new era of non-invasive, high-precision treatments for both malignant and benign brain tumors, as well as other neurological disorders. This launch strengthens Fortis’ position as a leader in advanced neurosurgical care in the region
- In April 2024, the AdventHealth Neuroscience Institute became the first center in Central Florida to deploy the Elekta Esprit Gamma Knife for brain treatments. This next-generation SRS system delivers precise ablative radiation with minimal impact on healthy tissues. The installation highlights growing adoption of advanced radiosurgical systems in U.S. regional hospitals
- In May 2022, Elekta launched the Elekta Esprit, a next-generation Gamma Knife platform designed to deliver personalized radiosurgery with sub-millimeter accuracy and rapid treatment planning under 60 seconds. It also features enhanced visualization, remote access, and collaboration tools for clinicians. This product launch expanded Elekta’s advanced radiosurgery portfolio and strengthened its market position
- In October 2021, Panacea Medical Technologies Pvt. Ltd. received FDA 510(k) clearance for its next-generation SBRT-enabled linear accelerator, built on a ring gantry platform. This innovation brings precision radiotherapy closer to a wider set of clinical applications. The clearance supported Panacea’s entry into the U.S. precision radiotherapy market
- In May 2020, Elekta introduced the Leksell Gamma Knife Lightning, the only fully integrated computerized treatment management system for Gamma Knife at the time. It featured plan optimization based on variables such as beam-on time. This innovation enhanced clinical efficiency and planning precision in radiosurgery practices
